Neuromed IRCCS
4 clinical trials · 4 recruiting · OTHER
Trials by Neuromed IRCCS
RECRUITINGNCT03217396
Biomarkers of Synaptic Damage in Multiple Sclerosis
A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients...
Sponsor: Neuromed IRCCSEnrolling: 3001 location
Multiple SclerosisParkinson DiseaseAmyotrophic Lateral Sclerosis+1
RECRUITINGNCT05811013
Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
In multiple sclerosis (MS) brains, inflammation induces specific abnormalities of synaptic transmission, collectively called inflammatory synaptopathy. Such synaptopathy consists...
Sponsor: Neuromed IRCCSEnrolling: 401 location
Progressive Multiple Sclerosis
RECRUITINGNCT05459090
Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.
Epilepsy is a neurological condition that afflicts 1% of the world population. 30% of patients become drug-resistant to classic antiepileptic treatment and only a small...
Sponsor: Neuromed IRCCSEnrolling: 601 location
Drug Resistant Epilepsy
RECRUITINGNCT06803784
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early...
Neurodegenerative disorders (NDDs), such as Parkinson¿s disease (PD), Alzheimer¿s disease (AD), Frontotemporal dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS) are...
Sponsor: Neuromed IRCCSEnrolling: 1101 location
Parkinson DiseaseAmyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia (FTD)+1